Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | METAP1 | P53582 | 2/20 | 0.57 |
| ▸ | MAPT | P10636 | 4/20 | 0.48 |
| ▸ | RAB9A | P51151 | 3/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.48 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 1/20 | 0.48 |
| ▸ | PKM | P14618 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 2/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.47 |
| ▸ | NPC1 | O15118 | 2/20 | 0.46 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.45 |
| ▸ | PARP11 | Q9NR21 | 1/20 | 0.45 |
| ▸ | ACHE | P22303 | 1/20 | 0.42 |
| ▸ | HPGD | P15428 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.41 |
| ▸ | CYP2A6 | P11509 | 2/20 | 0.41 |
| ▸ | MAOA | P21397 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29633547 | 1.00 | METAP1 (0.57) | METAP1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL29332473 | 0.95 | METAP1 (0.53) | METAP1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL21694418 | 0.93 | METAP1 (0.52) | METAP1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL18568790 | 0.91 | METAP1 (0.50) | METAP1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL30634708 | 0.89 | METAP1 (0.48) | METAP1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL21498294 | 0.89 | METAP1 (0.48) | METAP1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL31400232 | 0.89 | ALDH1A1 (0.59) | METAP1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL1609497 | 0.89 | ALDH1A1 (0.59) | METAP1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL24727167 | 0.87 | PGR (0.49) | METAP1MAPTRAB9AKDM4EALDH1A1 | |
| SCHEMBL9973088 | 0.87 | MAPT (0.62) | METAP1MAPTRAB9AKDM4EALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 75 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260092028-A1 | ONE-POT SYNTHESIS OF SUBSTITUTED FLOURENES | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2026-04-02 | — | — | US | disclosed |
| WO-2024075643-A1 | THERMOPLASTIC RESIN COMPOSITION AND OPTICAL MEMBER COMPRISING SAME | 帝人株式会社 | 2024-04-11 | — | — | WO | disclosed |
| CN-117756967-A | Silicon bridged metallocene catalyst and application thereof | 上海化工研究院有限公司 | 2024-03-26 | — | — | CN | disclosed |
| US-11760819-B2 | Ethylene α-olefin non-conjugated polyene copolymer, use thereof, and manufacturing method thereof | MITSUI CHEMICALS, INC. (JP) | 2023-09-19 | — | — | US | disclosed |
| US-11613595-B2 | Ethylene alpha-olefin non-conjugated polyene copolymer, use thereof, and manufacturing method thereof | MITSUI CHEMICALS, INC. (JP) | 2023-03-28 | — | — | US | disclosed |
| US-20220388958-A1 | CARBAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING CARBAZOLE DERIVATIVE | SEMICONDUCTOR ENERGY LABORATORY CO., LTD. (JP) | 2022-12-08 | — | — | US | disclosed |
| EP-4043500-A1 | ETHYLENE·ALPHA-OLEFIN·NON-CONJUGATED POLYENE COPOLYMER, USE THEREOF, AND MANUFACTURING METHOD THEREOF | Mitsui Chemicals, Inc. (JP) | 2022-08-17 | — | — | EP | disclosed |
| CN-109824809-B | Ethylene-alpha-olefin-nonconjugated polyene copolymer and use thereof | 三井化学株式会社 | 2022-06-28 | — | — | CN | disclosed |
| US-11312717-B2 | Organic nano-grid, nano-polymer thereof and preparation method therefor | NANJING UNIVERSITY OF POSTS AND TELECOMMUNICATIONS (CN) | 2022-04-26 | — | — | US | disclosed |
| EP-3106480-B1 | ETHYLENE/A-OLEFIN/NON-CONJUGATED POLYENE COPOLYMER, USE THEREFOR, AND MANUFACTURING METHOD THEREFOR | MITSUI CHEMICALS INC (JP) | 2022-04-06 | — | — | EP | disclosed |
| US-5426237-A | Oxidation of straight, branched or cyclic alkanes and benzene derivatives in presence of transition metal catalyst and aldehyde | SUMITOMO CHEMICAL CO., LTD. (JP) | 1995-06-20 | — | — | US | disclosed |
| US-5420320-A | Method for preparing cyclopentadienyl-type ligands and metallocene compounds | PHILLIPS PETROLEUM COMPANY (US) | 1995-05-30 | — | — | US | disclosed |
| EP-0627440-A1 | 9-Substituted fluorenyl compounds and the preparation and use of metallocenes thereof | PHILLIPS PETROLEUM COMPANY (US) | 1994-12-07 | — | — | EP | disclosed |
| EP-0577581-A2 | Method for controlling the melting points and molecular weights of syndiotactic polyolefins using metallocene catalyst systems | FINA TECHNOLOGY, INC. (US) | 1994-01-05 | — | — | EP | disclosed |
| EP-0531443-A4 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | — | 1993-04-21 | — | — | EP | disclosed |
| EP-0531715-A1 | Process for producing alcohols and ketones | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 1993-03-17 | — | — | EP | disclosed |
| EP-0531443-A1 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | NOVA PHARMACEUTICAL CORPORATION (US) | 1993-03-17 | — | — | EP | disclosed |
| US-5079260-A | Side effect reduction; fluorene derivatives | NOVA PHARMACEUTICAL CORPORATION (US) | 1992-01-07 | — | — | US | disclosed |
| WO-1991018596-A1 | METHODS FOR TREATING INFLAMMATION AND COMPOUNDS AND COMPOSITIONS SUITABLE FOR USE THEREIN | WEITZBERG MOSHE (US) | 1991-12-12 | — | — | WO | disclosed |
| US-4552830-A | UNSATURATED COMPOUND, FREE RADICAL-PRODUCING PHOTOINITIATOR FLUORA COLOR FORMER, PROTON DONOR | DYNACHEM CORPORATION (US) | 1985-11-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220388958-A1 | CARBAZOLE DERIVATIVE, AND LIGHT-EMITTING ELEMENT, LIGHT-EMITTING DEVICE, AND ELECTRONIC DEVICE USING CARBAZOLE DERIVATIVE | CRY1, AP3D1, AHR | METAP1 4122/4885MAPT 3816/4885RAB9A 1995/4885 |
| US-11312717-B2 | Organic nano-grid, nano-polymer thereof and preparation method therefor | ITGB2, CD81, ITGAV | METAP1 4865/4885MAPT 3845/4885RAB9A 4364/4885 |
| US-20260092028-A1 | ONE-POT SYNTHESIS OF SUBSTITUTED FLOURENES | DYRK1B, DYRK2, DYRK4 | METAP1 2580/4885MAPT 1992/4885RAB9A 632/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.